Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study

被引:3
|
作者
Ghosh, Subrata [1 ,2 ]
Antunes, Ana [3 ,9 ]
Rinta-Kokko, Hanna [4 ]
Chaparova, Elena [5 ]
Lay-Flurrie, Sarah [6 ]
Tricotel, Aurore [7 ]
Andersson, Fredrik L. [8 ]
机构
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] Univ Birmingham, Birmingham, England
[3] IQVIA, Real World Solut, Global Database Studies, Lisbon, Portugal
[4] IQVIA, Real World Solut, Global Database Studies, Espoo, Finland
[5] IQVIA, Real World Solut, Sofia, Bulgaria
[6] IQVIA, Real World Solut, London, England
[7] IQVIA, Real World Solut, Paris, France
[8] Ferring Pharmaceut, Copenhagen, Denmark
[9] IQVIA, Lagoas Pk,Edificio 3, P-2740266 Lisbon, Portugal
关键词
Clostridioides difficile infection; Recurrent clostridioides difficile infection; Epidemiological; Real-world study; England; RECUR; RISK; DISEASE;
D O I
10.1016/j.ijid.2024.01.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To estimate the epidemiological and clinical burden of Clostridioides difficile infections (CDIs) and recurrences (rCDIs) in England. Methods: This retrospective study included adult patients diagnosed with CDI (community or hospital settings) over 2015-2019 from Clinical Practice Research Datalink and Hospital Episode Statistics databases. Incidences of CDI and rCDI were determined annually. Time to subsequent rCDI was estimated by Kaplan-Meier method. Rates of complications were assessed within 12 months from index episode. Association of risk factors with complications was evaluated using a Cox regression model. Results: A total of 52,443 CDI episodes were recorded among 36,913 patients. Of these, 75% were aged >= 65 years, 59% were women; 73% were treated in community settings. CDI incidence remained stable (111 episodes per 10 0,0 0 0 patients in 2019). Around 21% of patients had >= 1 rCDI. Sepsis (12%) was the most common complication, followed by colectomy and ulcerative colitis. Age, gender, comorbidities, rCDI, preindex medical procedures, hospitalizations and consultations, and CDI treatment in hospital, were found to increase the risk of complication. Conclusions: CDI remains a concern in England. The study highlights the importance of managing primary and rCDI episodes via effective and improved therapies to prevent fatal complications. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [21] Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study
    Liu, Yuxiao
    Guo, Xiaofan
    Xu, Peijun
    Song, Yuning
    Huang, Jing
    Chen, Xingyun
    Zhu, Wenbo
    Hao, Jihui
    Gao, Song
    CANCER BIOLOGY & MEDICINE, 2024, 21 (09) : 799 - 812
  • [22] Real-World Safety and Clinical Outcomes of Macitentan in Asian Patients with Pulmonary Arterial Hypertension: A Prospective Multicenter Study
    Jung, Su Young
    Chang, Sung-A
    Song, Jong-Min
    Choi, Jae Young
    Kim, Hyung-Kwan
    Choi, Jung Hyun
    Chin, Jung Yeon
    Park, Minseok
    Kim, SuYoun
    Chang, Hyuk-Jae
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (01) : 41 - 49
  • [23] Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study
    Koh, Samuel Ji Quan
    Yap, Jonathan
    Jiang, Yilin
    Sng, Gerald Gui Ren
    Low, Yi Hua
    Lau, Yee How
    Sin, Yoong Kong Kenny
    Yeo, Khung Keong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 378 : 105 - 110
  • [24] Efficacy of Tocilizumab in Refractory Graves Orbitopathy From Real-World Clinical Practice: An Observational Study
    Wang, Mingyang
    Qin, Bixuan
    Liu, Cuihong
    Liu, Honglei
    Li, Dongmei
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (12)
  • [25] Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015
    Wang, Chen-Yu
    Huang, Huai-Hsuan
    Chen, Ho-Min
    Hsiao, Fei-Yuan
    Ko, Bor-Sheng
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (08) : E649 - E657
  • [26] Characterization and clinical outcomes of outpatients with subacute or chronic post COVID-19 cough: a real-world study
    Yao, Chun
    Cheng, Dongliang
    Yang, Wenhong
    Guo, Yun
    Zhou, Tong
    PEERJ, 2024, 12
  • [27] Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice survey
    Seetasith, Arpamas
    Holden, Michael
    Hetherington, James
    Keal, Aaron
    Salmon, Phoebe
    Bernstein, Jonathan A.
    Casale, Thomas B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (06) : 1059 - 1066
  • [28] Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS
    He, Luyao
    Yu, Yimin
    Wei, Yumei
    Huang, Jingjing
    Shen, Yifeng
    Li, Huafang
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [29] Clinical outcomes of high-intensity doses of atorvastatin in patients with acute coronary syndrome: A retrospective cohort study using real-world data
    Rahhal, Alaa
    Khir, Fadi
    Aljundi, Amer Hussien
    AlAhmad, Yaser
    Alzaeem, Hakam
    Habra, Masa
    Al-Shekh, Israa
    Mahfouz, Ahmed
    Awaisu, Ahmed
    Al-Yafei, Sumaya
    Arabi, Abdul Rahman
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 2043 - 2052
  • [30] The Relationship Between Age at Diabetes Onset and Clinical Outcomes in Newly Diagnosed Type 2 Diabetes: A Real-World Two-Center Study
    Chen, Mengdie
    Feng, Ping
    Liang, Yao
    Ye, Xun
    Wang, Yiyun
    Liu, Qiao
    Lu, Chaoyin
    Zheng, Qidong
    Wu, Lijing
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 4069 - 4078